Table 5
Simple dose reduction scheme for management of over-anticoagulation
INR
% dose reduction
Number (days) of omitted doses
Derived from Baglin.
41
Target INR 2.5
3.0–3.5
15
0
3.6–4.0
20
0
4.1–5.0
25
0
5.1–6.0
25
0
6.1–7.9
33
2
>8.0
50
3
Target INR 3.5
4.1–5.0
15
0
5.1–6.0
20
0
6.1–7.9
33
2
>8.0
50
3